Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial - Raskob, G E; Gallus, A S; Sanders, P (Thromb Haemost, 2016)
, et al.